Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication in Moderate ITP
NCT03177629Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- May 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pantoprazole, amoxicillin, clarithromycin, metronidazole in immune thrombocytopenic purpura (ITP), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
pantoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on NCT03177629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03177629.